Which has stronger valuation and earnings, CI or HUM?

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cigna Group $276.88B 0.27 $5.96B $23.59 11.99 Humana $137.20B 0.32 $1.19B $9.35 38.59

Is CI or HUM more profitable?

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Cigna Group 2.26% 19.75% 5.30% Humana 0.82% 10.45% 3.75%

Does the media favor CI or HUM?

In the previous week, Cigna Group had 21 more articles in the media than Humana. MarketBeat recorded 29 mentions for Cigna Group and 8 mentions for Humana. Cigna Group's average media sentiment score of 1.27 beat Humana's score of 0.33 indicating that Cigna Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cigna Group 24 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Humana 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation and earnings, CNC or HUM?

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Centene $194.78B 0.16 -$6.67B -$13.14 N/A Humana $137.20B 0.32 $1.19B $9.35 38.59

Is CNC or HUM more profitable?

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity. Company Net Margins Return on Equity Return on Assets Centene -3.25% 5.57% 1.54% Humana 0.82% 10.45% 3.75%

Does the media prefer CNC or HUM?

In the previous week, Centene had 4 more articles in the media than Humana. MarketBeat recorded 12 mentions for Centene and 8 mentions for Humana. Humana's average media sentiment score of 0.33 beat Centene's score of 0.32 indicating that Humana is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Centene 2 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Humana 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger valuation & earnings, ELV or HUM?

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Elevance Health $200.42B 0.43 $5.66B $23.51 16.80 Humana $137.20B 0.32 $1.19B $9.35 38.59

Is ELV or HUM more profitable?

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity. Company Net Margins Return on Equity Return on Assets Elevance Health 2.62% 15.58% 5.57% Humana 0.82% 10.45% 3.75%

Does the media favor ELV or HUM?

In the previous week, Elevance Health had 16 more articles in the media than Humana. MarketBeat recorded 24 mentions for Elevance Health and 8 mentions for Humana. Elevance Health's average media sentiment score of 1.65 beat Humana's score of 0.33 indicating that Elevance Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Elevance Health 23 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Humana 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger earnings and valuation, HUM or MOH?

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $137.20B 0.32 $1.19B $9.35 38.59 Molina Healthcare $45.43B 0.23 $472M $3.38 58.09

Does the media prefer HUM or MOH?

In the previous week, Humana and Humana both had 8 articles in the media. Molina Healthcare's average media sentiment score of 1.27 beat Humana's score of 0.33 indicating that Molina Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Molina Healthcare 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, HUM or UNH?

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Humana $137.20B 0.32 $1.19B $9.35 38.59 UnitedHealth Group $447.57B 0.83 $12.06B $13.24 30.86

Does the media prefer HUM or UNH?

In the previous week, UnitedHealth Group had 74 more articles in the media than Humana. MarketBeat recorded 82 mentions for UnitedHealth Group and 8 mentions for Humana. UnitedHealth Group's average media sentiment score of 1.30 beat Humana's score of 0.33 indicating that UnitedHealth Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Humana 2 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral UnitedHealth Group 66 Very Positive mention(s) 2 Positive mention(s) 8 Neutral mention(s) 5 Negative mention(s) 0 Very Negative mention(s) Positive

Humana (HUM) Competitors

$360.84 +0.12 (+0.03%)

As of 03:52 PM Eastern

Compare

HUM vs. CI, CNC, ELV, MOH, and UNH

Should you buy Humana stock or one of its competitors? MarketBeat compares Humana with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Humana include Cigna Group (CI), Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), and UnitedHealth Group (UNH). These companies are all part of the "managed health care" industry.

How does Humana compare to Cigna Group?

Cigna Group (NYSE:CI) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, institutional ownership, analyst recommendations, risk, valuation, media sentiment, dividends and profitability.

Cigna Group has higher revenue and earnings than Humana. Cigna Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cigna Group	$276.88B	0.27	$5.96B	$23.59	11.99
Humana	$137.20B	0.32	$1.19B	$9.35	38.59

In the previous week, Cigna Group had 21 more articles in the media than Humana. MarketBeat recorded 29 mentions for Cigna Group and 8 mentions for Humana. Cigna Group's average media sentiment score of 1.27 beat Humana's score of 0.33 indicating that Cigna Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cigna Group	24 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Humana	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

87.0% of Cigna Group shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.6% of Cigna Group shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Cigna Group pays an annual dividend of $6.24 per share and has a dividend yield of 2.2%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. Cigna Group pays out 26.5% of its earnings in the form of a dividend. Humana pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Cigna Group has increased its dividend for 5 consecutive years. Cigna Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Cigna Group currently has a consensus target price of $338.30, indicating a potential upside of 19.62%. Humana has a consensus target price of $291.35, indicating a potential downside of 19.26%. Given Cigna Group's stronger consensus rating and higher possible upside, research analysts plainly believe Cigna Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cigna Group	0 Sell rating(s)	6 Hold rating(s)	15 Buy rating(s)	1 Strong Buy rating(s)	2.77
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25

Cigna Group has a beta of 0.28, indicating that its stock price is 72% less volatile than the broader market. Comparatively, Humana has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Cigna Group has a net margin of 2.26% compared to Humana's net margin of 0.82%. Cigna Group's return on equity of 19.75% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cigna Group	2.26%	19.75%	5.30%
Humana	0.82%	10.45%	3.75%

Summary

Cigna Group beats Humana on 15 of the 19 factors compared between the two stocks.

How does Humana compare to Centene?

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, media sentiment, dividends, earnings, valuation and risk.

In the previous week, Centene had 4 more articles in the media than Humana. MarketBeat recorded 12 mentions for Centene and 8 mentions for Humana. Humana's average media sentiment score of 0.33 beat Centene's score of 0.32 indicating that Humana is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Centene	2 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral
Humana	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Humana has lower revenue, but higher earnings than Centene. Centene is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Centene	$194.78B	0.16	-$6.67B	-$13.14	N/A
Humana	$137.20B	0.32	$1.19B	$9.35	38.59

93.6% of Centene shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.4% of Centene shares are owned by company insiders. Comparatively, 0.2% of Humana shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Centene has a beta of 1.09, meaning that its stock price is 9% more volatile than the broader market. Comparatively, Humana has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

Centene currently has a consensus price target of $60.78, indicating a potential downside of 4.51%. Humana has a consensus price target of $291.35, indicating a potential downside of 19.26%. Given Centene's stronger consensus rating and higher probable upside, analysts clearly believe Centene is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Centene	2 Sell rating(s)	10 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25

Humana has a net margin of 0.82% compared to Centene's net margin of -3.25%. Humana's return on equity of 10.45% beat Centene's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Centene	-3.25%	5.57%	1.54%
Humana	0.82%	10.45%	3.75%

Summary

Humana beats Centene on 9 of the 16 factors compared between the two stocks.

How does Humana compare to Elevance Health?

Elevance Health (NYSE:ELV) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, profitability, analyst recommendations, institutional ownership, earnings, risk, media sentiment and valuation.

Elevance Health has a net margin of 2.62% compared to Humana's net margin of 0.82%. Elevance Health's return on equity of 15.58% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Elevance Health	2.62%	15.58%	5.57%
Humana	0.82%	10.45%	3.75%

89.2% of Elevance Health shares are owned by institutional investors. Comparatively, 92.4% of Humana shares are owned by institutional investors. 0.3% of Elevance Health shares are owned by insiders. Comparatively, 0.2% of Humana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Elevance Health had 16 more articles in the media than Humana. MarketBeat recorded 24 mentions for Elevance Health and 8 mentions for Humana. Elevance Health's average media sentiment score of 1.65 beat Humana's score of 0.33 indicating that Elevance Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Elevance Health	23 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Humana	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

Elevance Health presently has a consensus target price of $416.11, indicating a potential upside of 5.32%. Humana has a consensus target price of $291.35, indicating a potential downside of 19.26%. Given Elevance Health's stronger consensus rating and higher possible upside, analysts plainly believe Elevance Health is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Elevance Health	0 Sell rating(s)	9 Hold rating(s)	14 Buy rating(s)	0 Strong Buy rating(s)	2.61
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25

Elevance Health pays an annual dividend of $6.88 per share and has a dividend yield of 1.7%. Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. Elevance Health pays out 29.3% of its earnings in the form of a dividend. Humana pays out 37.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Elevance Health has raised its dividend for 14 consecutive years. Elevance Health is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Elevance Health has higher revenue and earnings than Humana. Elevance Health is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Elevance Health	$200.42B	0.43	$5.66B	$23.51	16.80
Humana	$137.20B	0.32	$1.19B	$9.35	38.59

Elevance Health has a beta of 0.67, indicating that its stock price is 33% less volatile than the broader market. Comparatively, Humana has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market.

Summary

Elevance Health beats Humana on 16 of the 20 factors compared between the two stocks.

How does Humana compare to Molina Healthcare?

Humana (NYSE:HUM) and Molina Healthcare (NYSE:MOH) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, dividends, institutional ownership, profitability, risk, earnings, analyst recommendations and valuation.

Humana has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.8, suggesting that its share price is 20% less volatile than the broader market.

In the previous week, Humana and Humana both had 8 articles in the media. Molina Healthcare's average media sentiment score of 1.27 beat Humana's score of 0.33 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
Molina Healthcare	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has a net margin of 0.82% compared to Molina Healthcare's net margin of 0.42%. Humana's return on equity of 10.45% beat Molina Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
Molina Healthcare	0.42%	8.76%	2.32%

92.4% of Humana shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 0.2% of Humana shares are owned by company insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Humana has higher revenue and earnings than Molina Healthcare. Humana is trading at a lower price-to-earnings ratio than Molina Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.32	$1.19B	$9.35	38.59
Molina Healthcare	$45.43B	0.23	$472M	$3.38	58.09

Humana currently has a consensus target price of $291.35, indicating a potential downside of 19.26%. Molina Healthcare has a consensus target price of $184.81, indicating a potential downside of 5.87%. Given Molina Healthcare's higher probable upside, analysts plainly believe Molina Healthcare is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25
Molina Healthcare	2 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.06

Summary

Humana beats Molina Healthcare on 10 of the 16 factors compared between the two stocks.

How does Humana compare to UnitedHealth Group?

Humana (NYSE:HUM) and UnitedHealth Group (NYSE:UNH) are both large-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk.

92.4% of Humana shares are held by institutional investors. Comparatively, 87.9% of UnitedHealth Group shares are held by institutional investors. 0.2% of Humana shares are held by insiders. Comparatively, 0.3% of UnitedHealth Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

In the previous week, UnitedHealth Group had 74 more articles in the media than Humana. MarketBeat recorded 82 mentions for UnitedHealth Group and 8 mentions for Humana. UnitedHealth Group's average media sentiment score of 1.30 beat Humana's score of 0.33 indicating that UnitedHealth Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Humana	2 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral
UnitedHealth Group	66 Very Positive mention(s)	2 Positive mention(s)	8 Neutral mention(s)	5 Negative mention(s)	0 Very Negative mention(s)	Positive

Humana has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market. Comparatively, UnitedHealth Group has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market.

Humana presently has a consensus target price of $291.35, indicating a potential downside of 19.26%. UnitedHealth Group has a consensus target price of $409.75, indicating a potential upside of 0.29%. Given UnitedHealth Group's stronger consensus rating and higher possible upside, analysts clearly believe UnitedHealth Group is more favorable than Humana.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Humana	3 Sell rating(s)	16 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.25
UnitedHealth Group	1 Sell rating(s)	4 Hold rating(s)	21 Buy rating(s)	1 Strong Buy rating(s)	2.81

UnitedHealth Group has a net margin of 2.68% compared to Humana's net margin of 0.82%. UnitedHealth Group's return on equity of 14.65% beat Humana's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Humana	0.82%	10.45%	3.75%
UnitedHealth Group	2.68%	14.65%	4.77%

Humana pays an annual dividend of $3.54 per share and has a dividend yield of 1.0%. UnitedHealth Group pays an annual dividend of $9.28 per share and has a dividend yield of 2.3%. Humana pays out 37.9% of its earnings in the form of a dividend. UnitedHealth Group pays out 70.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. UnitedHealth Group has raised its dividend for 15 consecutive years. UnitedHealth Group is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

UnitedHealth Group has higher revenue and earnings than Humana. UnitedHealth Group is trading at a lower price-to-earnings ratio than Humana, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Humana	$137.20B	0.32	$1.19B	$9.35	38.59
UnitedHealth Group	$447.57B	0.83	$12.06B	$13.24	30.86

Summary

UnitedHealth Group beats Humana on 15 of the 19 factors compared between the two stocks.

Get Humana News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

HUM vs. The Competition

Export

Metric	Humana	MED Industry	Medical Sector	NYSE Exchange
Market Cap	$43.32B	$53.23B	$6.47B	$23.13B
Dividend Yield	0.98%	1.76%	2.68%	4.06%
P/E Ratio	38.59	24.35	24.67	31.09
Price / Sales	0.32	0.64	518.45	20.82
Price / Cash	14.99	24.34	27.92	18.65
Price / Book	2.45	2.83	10.83	4.66
Net Income	$1.19B	$1.46B	$3.56B	$1.07B
7 Day Performance	-2.42%	-3.76%	1.75%	-1.06%
1 Month Performance	17.24%	0.00%	0.51%	0.17%
1 Year Performance	53.68%	-3.41%	32.92%	24.36%

Humana Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
HUM Humana	2.3993 of 5 stars	$360.84 +0.0%	$291.35 -19.3%	+50.5%	$43.32B	$137.20B	38.59	67,060
CI Cigna Group	4.9178 of 5 stars	$293.92 -1.4%	$338.80 +15.3%	-10.1%	$77.75B	$274.90B	12.46	67,700	Positive News Analyst Upgrade
CNC Centene	3.4193 of 5 stars	$63.34 -2.8%	$60.24 -4.9%	+16.9%	$31.28B	$198.10B	N/A	61,100	News Coverage Analyst Forecast
ELV Elevance Health	4.4905 of 5 stars	$401.19 -0.7%	$416.11 +3.7%	+5.7%	$87.12B	$199.13B	17.06	97,100	Positive News
MOH Molina Healthcare	3.2583 of 5 stars	$201.07 +0.4%	$182.73 -9.1%	-32.5%	$10.48B	$45.08B	59.49	19,000	Positive News Upcoming Earnings Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:HUM) was last updated on 6/23/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Summary

How does Humana compare to Centene?

Summary

How does Humana compare to Elevance Health?

Summary

How does Humana compare to Molina Healthcare?

Summary

How does Humana compare to UnitedHealth Group?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Humana (HUM) Competitors

HUM vs. CI, CNC, ELV, MOH, and UNH

How does Humana compare to Cigna Group?

Which has stronger valuation and earnings, CI or HUM?

Does the media favor CI or HUM?

Do institutionals & insiders have more ownership in CI or HUM?

Is CI or HUM a better dividend stock?

Do analysts prefer CI or HUM?

Which has more risk & volatility, CI or HUM?

Is CI or HUM more profitable?

Summary

How does Humana compare to Centene?

Does the media prefer CNC or HUM?

Which has higher valuation and earnings, CNC or HUM?

Do insiders and institutionals believe in CNC or HUM?

Which has more risk & volatility, CNC or HUM?

Do analysts recommend CNC or HUM?

Is CNC or HUM more profitable?

Summary

How does Humana compare to Elevance Health?

Is ELV or HUM more profitable?

Do institutionals & insiders believe in ELV or HUM?

Does the media favor ELV or HUM?

Do analysts recommend ELV or HUM?

Is ELV or HUM a better dividend stock?

Which has stronger valuation & earnings, ELV or HUM?

Which has more risk & volatility, ELV or HUM?

Summary

How does Humana compare to Molina Healthcare?

Which has more risk and volatility, HUM or MOH?

Does the media prefer HUM or MOH?

Is HUM or MOH more profitable?

Do institutionals and insiders believe in HUM or MOH?

Which has stronger earnings and valuation, HUM or MOH?

Do analysts prefer HUM or MOH?

Summary

How does Humana compare to UnitedHealth Group?

Do institutionals and insiders hold more shares of HUM or UNH?

Does the media prefer HUM or UNH?

Which has more risk and volatility, HUM or UNH?

Do analysts prefer HUM or UNH?

Is HUM or UNH more profitable?

Is HUM or UNH a better dividend stock?

Which has stronger valuation and earnings, HUM or UNH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

HUM vs. The Competition

Humana Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools